We are live on ! Find out more
EFTRW

eFFECTOR Therapeutics, Inc. Warrant
EFTRW

Delisted

EFTRW was delisted on the 2nd of July, 2024.

Back to rankings

16 hedge funds and large institutions have $798K invested in eFFECTOR Therapeutics, Inc. Warrant in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less funds holding

Funds holding: 17 → 16 (-1)

39% less capital invested

Capital invested by funds: $1.31M → $798K (-$515K)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
16
Holders Change
-1
Holders Change %
-5.88%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
4
Closed
2
Calls
$17K
Puts
–
Net Calls
+$17K
Net Calls Change
-$81K

Top Buyers

Rank Fund Capital Flow
1
ECM
Evolution Capital Management
Nevada
+$13.6K
2
PA
Parallel Advisors
California
+$2.94K

Top Sellers

Rank Fund Capital Flow
1
PVI
Pura Vida Investments
New York
-$35K
2
KSCM
Kamunting Street Capital Management
Florida
-$6K
3
WAM
Wolverine Asset Management
Illinois
-$4.35K
4
HF
HRT Financial
New York
-$1.11K
5
CH
CVI Holdings
Delaware
-$255
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Aristeia Capital
Connecticut
$379K – – –
HCM
2
Highbridge Capital Management
New York
$124K – – –
Goldman Sachs
3
Goldman Sachs
New York
$101K – – –
WA
4
Whitebox Advisors
Minnesota
$75K – – –
MI
5
MMCAP International
Cayman Islands
$36K – – –
CH
6
CVI Holdings
Delaware
$13K -$255 -942 -1%
PA
7
Parallel Advisors
California
$13K +$2.94K +10,833 +20%
ECM
8
Evolution Capital Management
Nevada
$13K +$13.6K +50,000 New
ICM
9
III Capital Management
Florida
$9K – – –
EPM
10
Equitec Proprietary Markets
Illinois
$8K – – –
TCM
11
Tenor Capital Management
New York
$8K – – –
CL
12
CSS LLC
Illinois
$7K – – –
WAM
13
Wolverine Asset Management
Illinois
$4K -$4.35K -16,067 -47%
HF
14
HRT Financial
New York
$4K -$1.11K -4,082 -17%
JG
15
Jefferies Group
New York
$2.5K – – –
UBS Group
16
UBS Group
Switzerland
$1K -$33 -120 -4%
PVI
17
Pura Vida Investments
New York
– -$35K -100,541 Closed
KSCM
18
Kamunting Street Capital Management
Florida
– -$6K -16,666 Closed

EFTRW Hedge Fund Activity: Q2 2022 in Review

16 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in eFFECTOR Therapeutics, Inc. Warrant (EFTRW) for Q2 2022, worth a combined $798K — down 39% from $1.31M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of EFTRW and 1 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 1 added.

The largest buyer was Evolution Capital Management, opening a new position worth an estimated $13.6K. The largest seller was Pura Vida Investments, exiting entirely with an estimated $35K sold.

  • 16 institutional investors held eFFECTOR Therapeutics, Inc. Warrant (EFTRW) as of Q2 2022, down from 17 in Q1 2022.
  • Funds reported $798K of eFFECTOR Therapeutics, Inc. Warrant stock for Q2 2022, down 39% quarter-over-quarter.
  • 1 fund opened new eFFECTOR Therapeutics, Inc. Warrant positions in Q2 2022 and 2 closed out, a net change of -1 holder.
  • The largest eFFECTOR Therapeutics, Inc. Warrant buyer in Q2 2022 was Evolution Capital Management, an estimated $13.6K added.
  • The largest eFFECTOR Therapeutics, Inc. Warrant seller in Q2 2022 was Pura Vida Investments, an estimated $35K sold.

Based on aggregated 13F filings for Q2 2022.